[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577577":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":45,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"University of Tennessee Graduate School of Medicine","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with presumed ovarian cancer",null,"Patients with presumed ovarian cancer will complete three, 4-hour study visits at the following time points:\n\n* The 1st visit will occur before treatment.\n* The 2nd visit will occur after about half of the planned treatment as been completed.\n* The 3rd visit will occur 4-8 weeks after the completion of treatment.",[13],"Other: High fat smoothie",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"High fat smoothie","Participants will consume a standardized 490 kcal high-fat smoothie, consisting of 57% fat, 23% carbohydrate, and 20% protein.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Jill M Maples, PhD","CONTACT","8653059367","jmaples1@utmck.edu",[26],{"facility":5,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Knoxville","Tennessee","37920","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-83.92074,35.96064,{"lat":37,"lon":36},[40],{"name":21,"role":22,"phone":10,"phoneExt":10,"email":24},{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100577577","dysregulation-of-whole-body-metabolism-in-ovarian-cancer-a-longitudinal-study-100577577",false,"NCT06800105","Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study","Inclusion Criteria:\n\n* Women\n* Age \\>18\n* Presumed ovarian cancer diagnosis (i.e. those being clinically evaluated for suspicion of ovary cancer)\n* Planned treatment course for ovarian cancer involving cytoreductive surgery followed by chemotherapy\n* Availability to commit to attending all study visits\n* Internet access and consistent access to phone\u002Femail\u002Ftext communication\n\nExclusion Criteria:\n\n* Pregnancy\n* Inability to provide voluntary informed consent\n* Inability to consume the pre-study visit meal\u002Fsnack and\u002For the study visit meal due to strict dietary restrictions\n* Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators\n* Circumstances and\u002For medical condition that would limit compliance with study requirements and protocol, as determined by the principal investigators","FEMALE","18 Years",{"count":52,"type":53},10,"ESTIMATED","OBSERVATIONAL","Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.",[57],"Ovary Cancer","2025-01-23",{"date":60,"type":61},"2025-01-29","ACTUAL",{"date":63,"type":61},"2023-03-22",{"date":65,"type":53},"2028-03-31",{"name":5,"class":6},1]